As a result of safety issues with DES — recently reinforced by the COURAGE study, and others, indicating that PCI/stenting may offer no greater length of life than medical therapy — utilization has declined substantially, particularly in the U.S. where usage has slumped from 87% of procedures in 2005 to the current rate of 64%, according to cardiologists at the ESC congress.
DES use: waiting for 2.0 resorbable?
January 2, 2015